| A Study of Mosliciguat in PH-ILD (NCT06635850) | Pulmovant, Inc. | 2024-10-29 |
| Investigating in Humans the Impact of Training Status on Dietary Consumption With Direct Measurement of Ingestive Behaviour (NCT07082582) | Michele Serra | 2024-10-29 |
| BEHAVIOR CHANGE INTERVENTION AFTER ENDOVASCULAR REVASCULARIZATION IN PAD (NCT07328646) | Muğla Sıtkı Koçman University | 2024-10-29 |
| IMPACT 360 for Parkinson's Disease (NCT07443293) | University of British Columbia | 2024-10-28 |
| A Single-center, Self-controlled, Prospective Case Series Pilot Study to Assess the Effect of Lamivudine (3TC) on Neurocognitive Impairment Biomarkers and Type-I IFN (Interferon)-Stimulated Genes in the Plasma of Patients With Mild Cognitive Impairment (MCI) (NCT06519357) | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 2024-10-28 |
| Narrative Enhancement and Cognitive Therapy for Self-Stigma in Youth (NCT06672562) | Centre for Addiction and Mental Health | 2024-10-28 |
| Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults (NCT06652100) | BioPorto Diagnostics | 2024-10-28 |
| Group Exercise Program Supported By Audiovisual Media During Hemodialysis (NCT06660160) | Cardenal Herrera University | 2024-10-28 |
| An Exploratory Study to Evaluate the Tolerability and Safety of MWAV201 in Subjects With Wilson Disease (NCT06663878) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2024-10-28 |
| Multi-omics in Severe Asthma From Olive Pollen Allergy (NCT07721376) | Maimónides Biomedical Research Institute of Córdoba | 2024-10-28 |
| Evaluation of a Smoking Cessation Program for Long-Term Abstinence (NCT06746025) | Quit Center LLC | 2024-10-28 |
| Analyzing Acoustic Properties of the Vowel "a" Collected Via Mobile Phone From Individuals Diagnosed With Chronic Obstructive Pulmonary Disease and Health Control Groups (NCT06705647) | Blekinge Institute of Technology | 2024-10-28 |
| A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis (NCT06551519) | Novartis Pharmaceuticals | 2024-10-28 |
| Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant. (NCT06645132) | Medical College of Wisconsin | 2024-10-28 |
| Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects (NCT07134478) | Haisco Pharmaceutical Group Co., Ltd. | 2024-10-28 |
| Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinomas (NCT06654297) | West China Hospital | 2024-10-27 |
| The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients (NCT06649773) | Jiangsu HengRui Medicine Co., Ltd. | 2024-10-25 |
| Piloting a School-Based Distress Tolerance Skills Program for Adolescents (NCT06638853) | Oregon Health and Science University | 2024-10-25 |
| Setrusumab in Pediatric Japanese Subjects With Osteogenesis Imperfecta (NCT06636071) | Ultragenyx Pharmaceutical Inc | 2024-10-25 |
| A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy (NCT06413706) | Eli Lilly and Company | 2024-10-25 |
| A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP) (NCT06508021) | Ashibio Inc | 2024-10-25 |
| ALS Phase II Study of NX210c (NCT06365216) | Axoltis Pharma | 2024-10-25 |
| Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy (NCT06671938) | BioArctic AB | 2024-10-24 |
| A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) (NCT06653153) | Eli Lilly and Company | 2024-10-24 |
| Long-term Outcomes Among Patients With Programmed Death-ligand 1 <1% Metastatic Non-small Cell Lung Cancer Treated With First-line Nivolumab + Ipilimumab + 2 Cycles of Chemotherapy (NCT07024862) | Bristol-Myers Squibb | 2024-10-24 |
| Research on Multimodal Multi-objective Integrated Machine Algorithm for Hip Replacement Surgery (NCT06689059) | Jingkun Liu | 2024-10-24 |
| Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation (NCT07084311) | n-Lorem Foundation | 2024-10-24 |
| Continuous Glucose Monitoring: A Pilot Study (NCT06614127) | Loma Linda University | 2024-10-24 |
| Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD) (NCT06602193) | Denali Therapeutics Inc. | 2024-10-24 |
| Study on Music Intervention of Non-clinical College Students (NCT06658431) | Ye Zhiyin | 2024-10-24 |
| A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer (NCT07553988) | R-Pharm International, LLC | 2024-10-24 |
| The Effect of Two Different Oral Care Solutions on the Prevention of Ventilator-associated Pneumonia in the Intensive Care Unit (NCT06733090) | MELEK UNLUGEDIK | 2024-10-23 |
| Assessing Central Aspects of Pain (NCT06518278) | University of Nottingham | 2024-10-23 |
| Feasibility of Day-surgery Management for Patients Undergoing Robotic Radical Prostatectomy: a Randomized Trial (NCT06891664) | Regina Elena Cancer Institute | 2024-10-23 |
| An Adapted Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Familial Hypercholesterolemia (DICA-FH) (NCT06331195) | Hospital do Coracao | 2024-10-23 |
| A Study of Single Dose of LP-003 in Healthy Adult Subjects (NCT06604949) | Longbio Pharma | 2024-10-23 |
| Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors (NCT06571422) | Shanghai Junshi Bioscience Co., Ltd. | 2024-10-23 |
| A Pilot Study of Local Anesthesia for Inguinal Hernia Surgery in Older Adults (NCT04706026) | University of Wisconsin, Madison | 2024-10-23 |
| A Safety and Efficacy Study of ARGX-119 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT06441682) | argenx | 2024-10-23 |
| Comprehensive SRS Regenerex Tissue Attachment (NCT06615739) | Zimmer Biomet | 2024-10-22 |
| A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight (NCT06649045) | Eli Lilly and Company | 2024-10-22 |
| Substance Use Treatment and Its Role in Supporting Social Cognition (NCT06535919) | Nova Southeastern University | 2024-10-22 |
| Chronic Coronary Syndrome Real Practice and Guidelines (NCT06684366) | Assiut University | 2024-10-22 |
| Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia. (NCT06356922) | Nantes University Hospital | 2024-10-22 |
| Clinical Investigation for Evaluating the Safety and Efficacy of JTM102 to Mid Face Volume Deficiency (NCT07265778) | Jetema Co., Ltd. | 2024-10-22 |
| Effect of Interceptive Strategies on the Clinical Outcome of Impacted Maxillary Permanent Canines (NCT06374329) | Universitaire Ziekenhuizen KU Leuven | 2024-10-22 |
| MVX-ONCO-2 in Advanced Solid Tumors (NCT05071846) | University Hospital, Geneva | 2024-10-22 |
| Sensory Profile and Academic Achievement in Students (NCT06659432) | Gazi University | 2024-10-22 |
| The Effectiveness of Virtual Reality in the Management of Procedural Anxiety and Pain in Children Suffering From Chronic Pathologies or Burn Injuries. (NCT06862830) | Meyer Children's Hospital IRCCS | 2024-10-22 |
| Post Marketing Surveillance of JARDIANCE in Chronic Kidney Disease (NCT06527846) | Boehringer Ingelheim | 2024-10-22 |
| A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL) (NCT06660563) | Janssen Research & Development, LLC | 2024-10-22 |
| Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L (NCT06539429) | Anterogen Co., Ltd. | 2024-10-22 |
| A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56 (NCT06668064) | EyePoint Pharmaceuticals, Inc. | 2024-10-22 |
| Registry Initiative Across Borders for Atrial Fibrillation in Africa (NCT06674304) | Mohammed VI University Hospital | 2024-10-22 |
| Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV. (NCT06321601) | Amgen | 2024-10-22 |
| Radiographic Migration Analysis of the ATTUNE Cementless CR Fixed-Bearing Total Knee Replacement (NCT06189872) | Canadian Radiostereometric Analysis Network | 2024-10-21 |
| A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). (NCT06551324) | Pfizer | 2024-10-21 |
| Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors (NCT06480526) | St. Jude Children's Research Hospital | 2024-10-21 |
| A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors (NCT06607185) | Eli Lilly and Company | 2024-10-21 |
| A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight (NCT06643728) | Eli Lilly and Company | 2024-10-21 |
| Evaluation of a Procedure for Identification and Brief Intervention of Lifestyle Advice Assisted by Application in a Care Setting (NCT06616064) | Rennes University Hospital | 2024-10-21 |
| Leniolisib for Immune Dysregulation in PIDs (NCT06549114) | Pharming Technologies B.V. | 2024-10-21 |
| Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections (NCT06549530) | Bavarian Nordic | 2024-10-21 |
| Esprit BTK Post-Approval Study (NCT06656364) | Abbott Medical Devices | 2024-10-21 |
| Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis (NCT06450886) | Abcuro, Inc. | 2024-10-21 |
| The Ladera Large Bore Closure Feasibility Study (NCT06358157) | Ladera Medical | 2024-10-21 |
| TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma (NCT06664983) | Sun Yat-sen University | 2024-10-21 |
| A Clinical Trial With KJ103 in Anti-GBM Disease (NCT06607016) | Shanghai Bao Pharmaceuticals Co., Ltd. | 2024-10-21 |
| Comparison of Noninvasive vs. Invasive Hemodynamic Measurements (NCT06689215) | Nihon Kohden | 2024-10-21 |
| Safety and Efficacy of Awake Uniportal Video Assisted Thoracoscopic Modified Pericardial Window in Recurrent Pericardial Effusion at Mid Term Result (NCT06972836) | Zagazig University | 2024-10-20 |
| AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer (NCT06591520) | Akeso | 2024-10-20 |
| Health Tourism in Bariatric Surgery (NCT06694831) | İlke Dolgun | 2024-10-20 |
| An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal Muscular Atrophy (NCT06288230) | Lantu Biopharma | 2024-10-20 |
| Use of Cannabis Oil in Fibromyalgia (NCT07194018) | Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria | 2024-10-19 |
| Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation (NCT06780930) | Servier | 2024-10-18 |
| A Phase 1 Study to Evaluate the Safety/Tolerability, PK/PD of RG002C0106 Injection in Healthy Adults (NCT06494527) | Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. | 2024-10-18 |
| Short-term Interruption Versus Continuous Anticoagulation in Colorectal Polypectomy (NCT07185295) | Outcomes'10 | 2024-10-18 |
| Evaluation of the Efficacy and Safety of Endoscopic Dilatation and Biological Therapy in Intestinal Stenosis Due to CD (NCT06603298) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2024-10-17 |
| A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China (NCT06640049) | GlaxoSmithKline | 2024-10-17 |
| Investigating a Brief Virtual Seminar Series for Parents of Teens Ages 13-17 (NCT06865196) | Texas Tech University | 2024-10-17 |
| CBT vs. Supportive Texts for PTSD & Hazardous Drinking (Project Better Study 2) (NCT06648395) | University of Washington | 2024-10-17 |
| Photobiomodulation Therapy for Scar Quality After Facial Wound Closure (NCT07523204) | Hani M. Al-Kufi | 2024-10-17 |
| Daratumumab in VHR T-ALL Treated According to the ALL National Treatment Program (NCT06253637) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2024-10-17 |
| IC14 for Treatment of Acute Decompensated Heart Failure (NCT06556810) | Implicit Bioscience | 2024-10-17 |
| Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation. (NCT07274761) | Shanghai Pulmonary Hospital, Shanghai, China | 2024-10-17 |
| Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa (NCT07352748) | Universita di Verona | 2024-10-17 |
| Robot Asissted Training on Neurodevelopmental Alterations (NCT06645795) | University of Valencia | 2024-10-17 |
| Mass Balance Clinical Trial of SIM0270 (NCT06654791) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2024-10-17 |
| A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) (NCT06643481) | Novartis Pharmaceuticals | 2024-10-17 |
| Stellest Lens Wear in Adult Progressing Myopes (NCT06520124) | University of Ulster | 2024-10-17 |
| Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa) (NCT06663176) | Thirty Respiratory Limited | 2024-10-16 |
| Acute Effects of Cold Exposure on Cognitive Function (NCT06654167) | Fudan University | 2024-10-16 |
| Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) (NCT06625320) | Revolution Medicines, Inc. | 2024-10-16 |
| A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation With Bordetella Pertussis Using Controlled Human Infection (NCT06903221) | Dimitri Diavatopoulos | 2024-10-16 |
| Prospective, Explorative, Research Study with Women to Investigate Menstruation Leakage At Night (NCT06637787) | Essity Hygiene and Health AB | 2024-10-16 |
| A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis (NCT06598462) | Uniquity One (UNI) | 2024-10-16 |
| A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine (NCT06581575) | Immorna Biotherapeutics, Inc. | 2024-10-16 |
| A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma (NCT06637371) | Amgen | 2024-10-16 |
| Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer (NCT06766019) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-16 |
| Acute Effects of Low Temperature Exposure on Respiratory System (NCT06652932) | Fudan University | 2024-10-16 |